Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | ALNY | ARGX | ||
| Company | Horizon Therapeutics | Alnylam Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 247.30 | 437.04 | ||
| High | 116.38 | 249.67 | 438.55 | ||
| Low | 116.26 | 245.48 | 433.35 | ||
| Last | 116.30 | 248.68 | 435.29 | ||
| Change | +0.05 | +1.07 | -0.20 | ||
| % Change | +0.04% | +0.43% | -0.05% | ||
| Volume | 28,881,200 | 950,100 | 197,700 | ||
| 20-Day Average Volume | 3,994,490 | 1,781,725 | 322,275 | ||
| Previous Close | 116.25 | 247.61 | 435.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 190.78 | 405.91 | ||
| 20-Day Raw Stochastic | 95.09% | 96.03% | 75.73% | ||
| 20-Day Relative Strength | 80.29% | 84.92% | 63.39% | ||
| Weighted Alpha | +49.30 | +18.51 | -1.27 | ||
| Today's Opinion | 88% Buy | 56% Buy | 24% Buy | ||
| Previous Opinion | 88% Buy | 56% Buy | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 40% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +1.43% since 06/26/24 | -2.38% since 06/26/24 | ||
| Low | 115.66 on 09/29/23 | 239.85 on 07/01/24 | 428.76 on 06/28/24 | ||
| High | 116.38 on 10/05/23 | 252.87 on 06/27/24 | 448.93 on 06/27/24 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +65.29% since 06/03/24 | +15.18% since 06/03/24 | ||
| Low | 114.75 on 09/11/23 | 147.25 on 06/07/24 | 368.57 on 06/10/24 | ||
| High | 116.38 on 10/05/23 | 252.87 on 06/27/24 | 456.68 on 06/26/24 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +64.87% since 04/03/24 | +9.23% since 04/03/24 | ||
| Low | 98.80 on 08/03/23 | 141.98 on 04/25/24 | 352.77 on 05/14/24 | ||
| High | 116.38 on 10/05/23 | 252.87 on 06/27/24 | 456.68 on 06/26/24 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +30.44% since 01/03/24 | +13.91% since 01/03/24 | ||
| Low | 90.56 on 05/16/23 | 141.98 on 04/25/24 | 349.86 on 03/20/24 | ||
| High | 116.38 on 10/05/23 | 252.87 on 06/27/24 | 456.68 on 06/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 31,456,028 | 25,869,716 | ||
| Shares Outstanding, K | 228,995 | 126,492 | 59,431 | ||
| Annual Sales | 3,629,040,000 | 1,828,290,000 | 1,268,590,000 | ||
| Annual Net Income | 521,480,000 | -440,240,000 | -295,050,000 | ||
| Last Quarter Sales | 944,960,000 | 494,330,000 | 412,510,000 | ||
| Last Quarter Net Income | 127,070,000 | -65,940,000 | -61,600,000 | ||
| 60-Month Beta | 1.03 | 0.37 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | -0.16 on 05/02/24 | -1.04 on 05/09/24 | ||
| Latest Earnings Date | 11/01/23 | 08/01/24 | 07/25/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 0.00 | 0.00 | ||